KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Change in Accured Expenses (2016 - 2025)

Tenet Healthcare's Change in Accured Expenses history spans 17 years, with the latest figure at -$41.0 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 68.94% year-over-year to -$41.0 million; the TTM value through Dec 2025 reached $9.0 million, up 200.0%, while the annual FY2025 figure was $9.0 million, 200.0% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$41.0 million at Tenet Healthcare, down from $26.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $100.0 million in Q3 2024 and bottomed at -$870.0 million in Q4 2022.
  • The 5-year median for Change in Accured Expenses is -$1.5 million (2023), against an average of -$73.4 million.
  • The largest YoY upside for Change in Accured Expenses was 5100.0% in 2024 against a maximum downside of 3400.0% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$592.0 million in 2021, then crashed by 46.96% to -$870.0 million in 2022, then skyrocketed by 100.46% to $4.0 million in 2023, then plummeted by 3400.0% to -$132.0 million in 2024, then soared by 68.94% to -$41.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Change in Accured Expenses are -$41.0 million (Q4 2025), $26.0 million (Q3 2025), and $32.0 million (Q2 2025).